Concurrent chemoradiotherapy combined with nimotuzumab in stage III-IVa nasopharyngeal carcinoma: a retrospective analysis.
Zhuochen CaiDongni ChenWenze QiuChixiong LiangYingying HuangJiayu ZhouZejiang ZhanYanqun XiangXiang GuoXing LvPublished in: Journal of cancer research and clinical oncology (2022)
CCRT combined with NTZ presented favorable clinical outcomes for stage III-IVa NPC patients with good tolerance and similar toxicity compared to CCRT alone. A prospective, randomized clinical trial is essential to validate the current findings.